The Directory of Open Access Journals
DOAJ Logotype
Open
Global
Trusted
Main actions
Support
Institutions and libraries
Publishers
Institutional and library supporters
Funders
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Search
Menu
Secondary actions
Search
Journals
Articles
Documentation
API
OAI-PMH
Widgets
Public data dump
OpenURL
XML
Metadata help
Preservation
About
About DOAJ
DOAJ at 20
DOAJ team
Ambassadors
Advisory Board & Council
Editorial Policy Advisory Group
Volunteers
News
Support
Institutions and libraries
Publishers
Institutional and library supporters
Funders
Apply
Application form
Guide to applying
The DOAJ Seal
Transparency & best practice
Publisher information
Licensing & copyright
Login
Login
Quick search
Close
×
Journals
Articles
Search by keywords:
In the field:
In all fields
Title
ISSN
Subject
Publisher
Country of publisher
Search
Frontiers in Pharmacology
(Feb 2022)
Corrigendum: TNF-α in Uveitis: From Bench to Clinic
Qi Jiang,
Zhaohuai Li,
Tianyu Tao,
Runping Duan,
Xianggui Wang,
Xianggui Wang,
Wenru Su
Affiliations
Qi Jiang
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
Zhaohuai Li
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
Tianyu Tao
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
Runping Duan
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
Xianggui Wang
Eye Center of Xiangya Hospital, Central South University, Changsha, China
Xianggui Wang
Hunan Key Laboratory of Ophthalmology, Changsha, China
Wenru Su
State Key Laboratory of Ophthalmology, Zhongshan Ophthalmic Center, Sun Yat-sen University, Guangzhou, China
DOI
https://doi.org/10.3389/fphar.2022.817235
Journal volume & issue
Vol. 13
Abstract
Read online
No abstracts available.
Keywords
uveitis
TNF-α
experimental autoimmune uveitis (EAU)
anti-TNF-α agents
infliximab
adalimumab
WeChat QR code
Close